US pharmaceutical distributor Cardinal Health
agrees to pay $470 million for China’s largest pharmaceutical importer,
Zuellig Pharma China, known locally as Yong Yu.
The Export-Import Bank of China captures robust
investor demand with its third offshore renminbi bond. The $700 million
issue tightens sharply in the secondary market, which is testament to
the ferocious appetite for so-called dim sum bonds.
After shelving a $96 million New York IPO in May,
Chinese upstream oil company MIE is looking to raise $184 million from a
new share sale in Hong Kong.
You should invest in Brazil not just because the
Bric country will host the World Cup and the Olympic Games within the
next decade, but because its economic fundamentals are sound.